mussel RNA (Fig. lh) , even under more stringent washing conditions (55°C. 0.5 x SSC). These observations are in agreement with the proposal that the 1'-450 II family is of comparatively recent origin and might not be present in lower organisms, whereas the P 4 5 0 IV family is of more ancient origin [6, 71. It might be expected therefore that sequences homologous to 1'-450 lVAl would be expressed in lower organisms and indeed preliminary work in this laboratory has detected homology to RNA from a range of marine invertebrates.
We have also detected sequences homologous to the 1'-450 lVAl probe in mussel genomic DNA; however, much less stringent washing conditions were required (37"C, 2 x SSC) owing to the presence of intron sequences.
BIOCHEMICAL SOCIETY TRANSACTIONS
In a Northern blot comparing rat and mussel RNA (Fig.  lc) , hybridization of the 1'-450 IVAl probe is again observed. The size of the mRNA would appear to be smaller than the major 2.1 kb rat 1'-450 lVAl band. Conclusions about the identity of this mRNA and corresponding protein function must therefore await the isolation of the cDNA.
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7. Thc carcinogenic properties of 7,12-dimethylbenz( u)anthracenc (DMBA) are dependent o n metabolic conversion t o the bay region diol-epoxidc, DMBA-3,4-diol-I ,2-oxide (DMBA-DO) and this ultimate carcinogen is formed by sequential reactions which arc catalysed by cytochrome(s) 1'-4SO
(1'-450) and cpoxide hydrolase (EH) 1 1 1 :
DMBA-DO
Formation of DMBA oxides at other ring positions produces less potent procarcinogens.
We have identified some P -4 5 0~ which arc important in the formation of the proximate carcinogen (DMBA-3,4-diol) and in the formation of diols which are without adverse effect (DMBA-5,6-and -8,9-diols). A major determinant in the formation of DMBA-3,4-diol is I'-450-PB 1 (1'-45011C) [2] , while P-450-MClb (P-450IAl) produces only small amounts of this metabolite, but is highly active in thc formation o f diols at the -5,6-and -8,Y-positions [2, 31. Indirect evidence from studies of the formation of DMBA-membrane protein adducts in vitro suggest that P4.50-PB3a (1'- 45011B1) may play some role in the second P-450-mediated oxidation during ultimate carcinogen formation [ 2 ] .
The current study was initiated to idcntify other I'-450s which may be important in the formation of DMBA metabolites and adducts and has utilized microsomal membranes from animals treated with selective inducers of I'-45O-isoenzymes. A protocol has been developed for the measurement of DMBA-protein and DMBA-DNA adducts in the same reaction mixtures. In parallel with these studies, rates of formation of DMBA diols have also been determined. Adduct formation was determined in reaction mixtures containing membranes ( 1 mg of protein/ml), NADPH, 13H]DMBA and exogenous calf-thymus DNA. Ater a 1 h incubation, reaction was stopped by cooling and the mcmbranes were recovered by centrifugation at 100 000 g,,;,, for 1 h. DNA was recovered from the supernatant by precipitation with ethanol and the resulting pellet was washed with 70% (v/v) ethanol before determination of radioactivity and DNA content. The membrane pellet was extracted with chloroform/methanol to remove unreacted DMBA, DMBA metabolites and DMBA-lipid adducts. The solvent-extracted proteins were hydrolysed with sodium hydroxide before determination of radioactivity and protein content. Rates o f adduct formation are expressed as pmol o f DMBA min ~ ' mg-I protein or DNA.
Microsomal membranes were prepared from the livers o f untreated Long-Evans rats and animals pretreated with phenobarbital, Sudan Ill, dexamethasone, pyrazole or clofibrate. The effect of these inducing agents on the rates of formation of DMBA-diols is shown in Fig. l(a) . Pretreatment of animals with phenobarbital and Sudan 111 produces distinctive changes in the regio-selective metabolism of DMBA which we have previously reported 12, 31. The formation of Microsomal membranes prepared from untreated ( U ) animals and animals treated with phenobarbital (PB), Sudan 111 (S). dexamethasone (D), pyrazole ( P ) and clofibrate (C) were incubated in the presence of I7HlDBMA. The rate of formation o f DMBA diols ( t i ) was determined by ethyl acetate extraction followed by normal phase h.p.1.c. as described 12 1 . In parallel experiments, the formation of DMBA-protein adducts ( b ) and DMBA-DNA adducts ( c ) were determined as described in the text.
DMBA-3,4-diol was decreased when microsomal membranes from animals treated with dexamethasone and pyrazole were used to 2 1 *% and 44% of untreated-membranes, respectively. The formation of the -5,6-and -8,9-diols in thesc membranes was not significantly altered. When membranes from clofibrate-treated animals were used, formation of the -5,6-diol was increased by 3.3-fold, while formation of the -3.4-and -8,9-diols were unaltered.
The formation of adducts between DMBA metabolites and membrane proteins was altered by pretreatment of the animals with the inducing agents (Fig. 1 b) . Pretreatment with phenobarbital, Sudan Ill and dexamethasone increased these rates by 5.9-, 4.2-and 3.7-fold, respectively, relative to membranes from untreated animals. This was in contrast to a decrease in formation of DMBA-protein adducts in membranes from pyrazole-treated animals to 60% of the value found for membranes from untreated animals. Pretreatment with clofibrate increased DMBA-protein adduct formation, but only by a marginal amount. The rates of formation of DMBA-DNA adducts (Fig. 1 c) were approximately 20-fold lower than formation of DMBA-protein adducts, but the pattern of variation of both types of adducts between the different membrane preparations were similar. An increase in adduct formation was found when membranes from phenobarbital-(5.6-fold increase), Sudan 111-(4.7-fold) and dexamethasone-treated animals (4.6-fold) were used. DNAadduct formation in membranes from pyrazole-treated animals was decreased to 754L of untreated value, while there was a small increase (2-fold) with membranes from clofibrate-treated animals.
The results obtained with melhbranes from pyrazole-and clofibrate-treated animals indicate that I'-450j (P4SOIlE 1 ) and I-'-450 LAW (1'-450IVA1) do not play a major role in the formation of DMBA diols or adducts of DMBA metabolites and membrane proteins or DNA. The decrease in DMBA-3,4-diol and DMBA-protein adduct formation in membranes from pyrazole-treated animals is likely to be related to the suicide-inhibitory properties of this agent [4] , possibly by a selective effect on P-450-PB1. The changes in the formation of DMBA-protein adducts following phenobarbital and Sudan 111 treatment are similar to those previously reported [2] . The identity of the metabolites formed by these membranes, which are involved in adduct formation is not known, but some evidence indicates that in the phenobarbital-treated membranes a secondary metabolite and in the Sudan Ill-treated membranes primary metabolites may be the reactive species. DMBA-DNA adducts were formed at considerably slower rates than DMBA-protein adducts, but the magnitude of change elicited by each inducer was similar for both types of adduct. Dexamethasone decreased the formation of DMBA-3,4-diol, possibly by suppressing the expression of P450-PBl [S], but increased the formation of both DMBA-protein and DMBA-DNA adducts. Observations reported here do not permit the identification of f'-4SO(s) involved in the metabolism of DMBA to the ultimate carcinogen and to other reactive products. The protocol does, however, provide a framework for such a study in which the formation of specific, spectrally identified DMBA-DNA adducts can be measured and the effects of inhibitors of specific P 4 5 0 isoenzymes investigated.
